{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T14:21:25Z","timestamp":1778422885270,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.clinthera.2013.09.020","type":"journal-article","created":{"date-parts":[[2013,10,19]],"date-time":"2013-10-19T12:00:23Z","timestamp":1382184023000},"page":"1884-1889","source":"Crossref","is-referenced-by-count":14,"title":["Pharmacokinetics and Tolerability of Tenofovir Disoproxil Fumarate 300 mg Once Daily: An Open-Label, Single- and Multiple-Dose Study in Healthy Chinese Subjects"],"prefix":"10.1016","volume":"35","clinical-trial-number":[{"clinical-trial-number":"nct01480622","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Chao-ying","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-ying","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-xuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuening","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2013.09.020_bib1","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1128\/AAC.38.9.2180","article-title":"Inhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue culture","volume":"38","author":"Heijtink","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2013.09.020_bib2","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/hep.20723","article-title":"Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir","volume":"41","author":"Brunelle","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2013.09.020_bib3","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.00138-06","article-title":"Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus","volume":"50","author":"Delaney","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2013.09.020_bib4","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/AAC.01440-06","article-title":"In vitro activity of 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine against multidrug-resistant hepatitis B virus mutants","volume":"51","author":"Brunelle","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2013.09.020_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/135965350400900311","article-title":"In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir","volume":"9","author":"Lada","year":"2004","journal-title":"Antivir Ther"},{"key":"10.1016\/j.clinthera.2013.09.020_bib6","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.20464","article-title":"Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection","volume":"40","author":"Van B\u00f6mel","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2013.09.020_bib7","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1542-3565(04)00017-5","article-title":"Tenofovir disoproxil fumarate for the treatment of lamivudine-resistant hepatitis B","volume":"2","author":"Kuo","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2013.09.020_bib8","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1345\/aph.1E280","article-title":"Tenofovir therapy for lamivudine resistance following liver transplantation","volume":"38","author":"Neff","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2013.09.020_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.21253","article-title":"Tenofovir for patients with lamivudine resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy","volume":"44","author":"Van B\u00f6mel","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2013.09.020_bib10","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1086\/496921","article-title":"Treatment of chronic hepatitis B in HIV infected persons: thinking outside the black box","volume":"41","author":"Thio","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2013.09.020_bib11","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/hep.21388","article-title":"Randomised controlled study to tenofovir and adefovir in chronic hepatitis B virus and HIV co-infection: ACTG A5127","volume":"44","author":"Peters","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2013.09.020_bib12","unstructured":"State Food and Drug Administration of China. Guideline for good clinical principles. http:\/\/www.sda.gov.cn\/WS01\/CL0053\/24473.html. Accessed August 6, 2003."},{"key":"10.1016\/j.clinthera.2013.09.020_bib13","unstructured":"World Medical Association (WMA). Declaration of Helsinki. Ethical principles for medical research involving human subjects. Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964, and amended by the 52nd WMA General Assembly, Edinburgh, Scotland, October 7, 2000. http:\/\/www.wma.net\/en\/30publications\/10policies\/b3\/. Accessed October, 2008."},{"key":"10.1016\/j.clinthera.2013.09.020_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.5414\/CPP46627","article-title":"Pharmacokinetics of emtricitabine\/tenofovir disoproxil fumarate and tacrolimus at steady state when administered alone or in combination","volume":"46","author":"Chittick","year":"2008","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2013.09.020_bib15","unstructured":"China Food and Drug Administration, Center for Drug Evaluation. Guidance for clinical pharmacokinetics studies of chemical drug. http:\/\/www.cde.org.cn\/zdyz.do?method=largePage&id=2070. Accessed August 30, 2013."},{"key":"10.1016\/j.clinthera.2013.09.020_bib16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2165\/00003088-200443090-00003","article-title":"Tenofovir disoproxil fumarate clinical pharmacology and pharmacokinetics","volume":"43","author":"Kearney","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2013.09.020_bib17","unstructured":"Kearney BP, Flaherty JF, Sayre JR, et al. Effect of formulation and food on the pharmacokinetics of tenofovir DF. Presented at: 2nd International Workshop on Clinical Pharmacology of HIV Therapy, April 2-4, 2001, Noordwijk, the Netherlands. Poster no. 3.18."},{"key":"10.1016\/j.clinthera.2013.09.020_bib18","unstructured":"Flaherty JF, Kearney BP, Wolf JJ, et al. A multiple-dose, randomized, crossover drug interaction study between tenofovir DF and efavirenz, indinavir, or lopinavir\/ritonavir. Presented at: 1st IAS Conference on HIV Pathogenesis and Treatment, July 8\u201311, 2001n Buenos Aires, Argentina. Poster no. 336."},{"key":"10.1016\/j.clinthera.2013.09.020_bib19","unstructured":"Kearney BP, Flaherty JF, Sayre JR, et al. A multiple-dose, randomized, crossover drug interaction study between tenofovir DF and lamivudine or didanmosine. Presented at: 1st IAS Conference on HIV Pathogenesis and Treatment, July 8\u201311, 2001, Buenos Aires, Argentina. Poster no. 337."},{"key":"10.1016\/j.clinthera.2013.09.020_bib20","unstructured":"Gilead. Viread [prescribing information]. http:\/\/www.gilead.com\/~\/media\/Files\/pdfs\/medicines\/hiv\/complera\/complera_pi.pdf. Accessed August 30, 2013."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291813009715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291813009715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T12:24:50Z","timestamp":1688559890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291813009715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0149291813009715"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2013.09.020","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}